Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases-Reference-Cited by-同舟云学术

Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases

Published:2017-04-20 Issue:2 Volume:10 Page:
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Bisht Rohit¹,Mandal Abhirup²,Jaiswal Jagdish K.³,Rupenthal Ilva D.¹^ORCID

Affiliation:

1. Buchanan Ocular Therapeutics Unit (BOTU), Department of Ophthalmology, New Zealand National Eye Center, Faculty of Medical and Health Sciences University of Auckland Auckland New Zealand

2. Division of Pharmaceutical Sciences, School of Pharmacy University of Missouri‐Kansas City Kansas City MO USA

3. Auckland Cancer Society Research Center, Faculty of Medical and Health Sciences University of Auckland Auckland New Zealand

Funder

University of Auckland

Health Research Council of New Zealand

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1473

Reference155 articles.

1. Drug delivery to the posterior segment of the eye

2. Posterior Segment Drug Delivery Devices: Current and Novel Therapies in Development

3. Undefined role of mucus as a barrier in ocular drug delivery

4. Eye: anatomy, physiology and barriers to drug delivery

5. Barrier Function in the Ocular Surface: From Conventional Paradigms to New Opportunities

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-based nanocarriers mediated Axitinib retinal delivery after topical instillation: Formulations setting up and in vivo evidence;Journal of Drug Delivery Science and Technology;2024-10

2. Nano-Based Drug Approaches to Proliferative Vitreoretinopathy Instead of Standard Vitreoretinal Surgery;International Journal of Molecular Sciences;2024-08-09

3. Expanding Arsenal against Ocular Diseases through Nanoemulsion: Success So Far and the Road Ahead;Current Drug Delivery;2024-07-15

4. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments;International Journal of Biological Macromolecules;2024-07

5. Intravitreal therapeutic nanoparticles for age-related macular degeneration: Design principles, progress and opportunities;Advances in Colloid and Interface Science;2024-07